Biotechnology company developing and manufacturing bovine milk-derived exosomes at industrial scale as a drug-delivery platform
Biotechnology company developing and manufacturing bovine milk-derived exosomes at industrial scale as a drug-delivery platform. Its proprietary processes isolate exosomes and precision-load therapeutic peptides, RNAs, biologics, and small molecules for pharmaceutical partners. The company is also advancing XOlacta, an orally administered exosome-delivered cardioprotectant and radioprotectant.
The top three firms on F4's Biotech & Life Sciences investor list.